Orexigen Therapeutics Ireland Limited

Orexigen Therapeutics Ireland Limited is the European marketing authorisation holder for Mysimba (naltrexone/bupropion prolonged-release tablets), licensed in the UK for chronic weight management in obese or overweight adults with weight-related comorbidities. Mysimba is distributed in the UK through Consilient Health Ltd. The company is a subsidiary of the Currax Pharmaceuticals group.

How to contact Orexigen Therapeutics Ireland Limited

Address

2nd Floor, Palmerston House, Fenian Street, Dublin 2, Ireland

Fax

020 3905 2657

Browse medications manufactured by Orexigen Therapeutics Ireland Limited